Novel therapeutic target for cancer stem cells in hepatocellular carcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 19, Issue 6, 2012, Pages 600-605

  Nagano, Hiroaki ^a   Ishii, Hideshi ^a   Marubashi, Shigeru ^a   Haraguchi, Naotsugu ^a   Eguchi, Hidetoshi ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Cancer; Cancer stem cell; Hepatocellular carcinoma

Indexed keywords

BESTATIN; CANCER ANTIBODY; CD13 NEUTRALIZING ANTIBODY; CD133 ANTIGEN; CD24 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; FLUOROURACIL; MICROSOMAL AMINOPEPTIDASE; REACTIVE OXYGEN METABOLITE; THY 1 ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CELL COUNT; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL HYPOXIA; CELL PROLIFERATION; CELL REGENERATION; CELL SELECTION; CELL SURVIVAL; EPIGENETICS; HEMATOPOIETIC CELL; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN FUNCTION; SIDE POPULATION CELL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; NEOPLASTIC STEM CELLS; TISSUE THERAPY;

EID: 84872177220     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-012-0543-5     Document Type: Article

References (44)

1. Nowell PC. Chromosomes and cancer: the evolution of an idea. Adv Cancer Res. 1993;62:1-17.
2. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993;9:138-41.
3. Hickman ES, Moroni MC, Helin K. The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev. 2002;12:60-6. (Pubitemid 34094991)
4. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3:459-65.
5. Waterland RA. Epigenetic mechanisms and gastrointestinal development. J Pediatr. 2006;149:S137-42. (Pubitemid 44278867)
6. Sagar J, Chaib B, Sales K, Winslet M, Seifalian A. Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int. 2007;7:9.
7. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-11.
8. Giordano A, Fucito A, Romano G, Marino IR. Carcinogenesis and environment: the cancer stem cell hypothesis and implications for the development of novel therapeutics and diagnostics. Front Biosci. 2007;12:3475-82.
9. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66(19):9339-44.
10. Bixby S, Kruger GM, Mosher JT, Joseph NM, Morrison SJ. Cellintrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron. 2002;35:643-56.
11. Tan BT, Park CY, Ailles LE, Weissman IL. The cancer stem cell hypothesis: a work in progress. Lab Invest. 2006;86:1203-7. (Pubitemid 44789910)
12. Wulf GG, Wang RY, Kuehnle I, Weinder D, Marini F, Brenner MK, et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood. 2001;98(4):1166-73.
13. Lapidot T, Sirard C, Vormoor J, Murdioch B, Hoang T, Caceres- Cortes J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature. 1994;367(6464): 645-8. (Pubitemid 24067706)
14. Bonnet D, Dick JE. Human acute leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730-7. (Pubitemid 27298715)
15. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104(3):973-8. (Pubitemid 46154721)
16. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells. 2006; 24(3):506-13.
17. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human coloncancer- initiating cells. Nature. 2007;445(7123):111-5. (Pubitemid 46067311)
18. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106-10.
19. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-8. (Pubitemid 36418143)
20. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444(7120):761-5. (Pubitemid 44949605)
21. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60.
22. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem/ progenitor cells. Gastroenterology. 2007;132:2542-56.
23. Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY. CD133? HCC cancer stem cells confer chemoresistance by preferential expression of the akt/pkb survival pathway. Oncogene. 2008; 27:1749-58.
24. Fan L, He F, Liu H, Zhu J, Liu Y, Yin Z, et al. Cd133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer. 2011;11:320.
25. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90? cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153-66.
26. Endo K, Terada T. Protein expression of cd44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol. 2000;32:78-84.
27. Kimura O, Takahashi T, Ishii N, Inoue Y, Ueno Y, Kogure T, et al. Characterization of the epithelial cell adhesion molecule (EpCAM)? cell population in hepatocellular carcinoma cell lines. Cancer Sci. 2010;101:2145-55.
28. Wu C, Alman BA. Side population cells in human cancers. Cancer Lett. 2008;268:1-9.
29. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax DW, Gobel U, et al. A distinct ''side population'' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA. 2004;101:14228-33.
30. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2): 149-61.
31. Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, et al. Cd13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 2010;120(9):3326-39.
32. Guan Y, Gerhard B, Hogge DE. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood. 2003; 101(8):3142-9. (Pubitemid 36858008)
33. Holyoake T, Jiang X, Eaves C, Eaves A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood. 1999;94(6):2056-64.
34. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7):2557-76.
35. Ashmun RA, Shapiro LH, Look AT. Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies. Blood. 1992;79(12):3344-9.
36. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest. 1989;83(4):1299-307.
37. Ashmun RA, Look AT. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood. 1990;75(2):462-9. (Pubitemid 20035279)
38. Nakamura H, Suda H, Takita T, Aoyagi T, Umezawa H. X-ray structure determination of (2S, 3R)-3-amino-2-hydroxy-4- phenylbutanoic acid, a new amino acid component of bestatin. J Antibiot. 1976;29(1):102-3.
39. Mathe G. Bestatin, an aminopeptidase inhibitor with a multipharmacological function. Biomed Pharmacother. 1991;45(2-3): 49-54.
40. Kobayashi T, Miyawaki S, Tanimoto M, Kuriyama K, Murakami H, Yoshida M, et al. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/ intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. J Clin Oncol. 1996;14(1):204-13.
41. Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97-106.
42. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499-507.
43. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90? cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153-66.
44. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology. 2008;47:919-28.